Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CNTX
CNTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CNTX News
Context Therapeutics Added to Russell Indices
1d ago
NASDAQ.COM
CTIM-76 Early Data Triggers Stock Plunge
Jun 15 2026
stocktwits
CTIM-76 Shows Promising Interim Results in Ovarian Cancer Trial
Jun 15 2026
NASDAQ.COM
Context Therapeutics Reports Positive Interim Data for CTIM-76 in Ovarian Cancer
Jun 15 2026
Newsfilter
Context Therapeutics Grants Stock Options to New Employee
Jun 09 2026
Newsfilter
Context Therapeutics Grants Stock Options to New Employee
May 27 2026
Newsfilter
Context Therapeutics Reports Q1 Financials with Cash Position Update
May 07 2026
seekingalpha
Context Therapeutics Receives FDA Fast Track Designation for CTIM-76
Apr 02 2026
seekingalpha
Context Therapeutics Receives FDA Fast Track Designation for CTIM-76
Apr 02 2026
NASDAQ.COM
FDA Grants Fast Track Designation to CTIM-76 for Ovarian Cancer
Apr 02 2026
Newsfilter
Context Therapeutics Reports Wider Losses in FY2025 and Pipeline Updates
Mar 24 2026
NASDAQ.COM
Context Therapeutics Reports FY GAAP EPS
Mar 23 2026
seekingalpha
Context Therapeutics Announces Upcoming Investor Conference Schedule
Feb 09 2026
Newsfilter
Context Therapeutics Grants 120,000 Stock Options to Attract New Employees
Jan 16 2026
Globenewswire
Alumis Inc. (ALMS) Shares Surge 17.33% on Phase 3 Clinical Trial Data Announcement
Jan 06 2026
NASDAQ.COM
GH Research PLC Shares Surge 18.1% on FDA IND Status Update Announcement
Jan 05 2026
Benzinga
Show More News
